LGND logo

LGND CAPEX

annual CAPEX:

$19.64M-$34.21M(-63.53%)
December 31, 2024

Summary

  • As of today (June 4, 2025), LGND annual capital expenditures is $19.64 million, with the most recent change of -$34.21 million (-63.53%) on December 31, 2024.
  • During the last 3 years, LGND annual CAPEX has risen by +$10.88 million (+124.18%).
  • LGND annual CAPEX is now -82.06% below its all-time high of $109.47 million, reached on December 31, 2002.

Performance

LGND CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDcash flow metrics

quarterly CAPEX:

$2.04M+$1.32M(+185.81%)
March 31, 2025

Summary

  • As of today (June 4, 2025), LGND quarterly capital expenditures is $2.04 million, with the most recent change of +$1.32 million (+185.81%) on March 31, 2025.
  • Over the past year, LGND quarterly CAPEX has dropped by -$513.00 thousand (-20.13%).
  • LGND quarterly CAPEX is now -98.09% below its all-time high of $106.58 million, reached on December 31, 2002.

Performance

LGND quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDcash flow metrics

TTM CAPEX:

$19.13M-$513.00K(-2.61%)
March 31, 2025

Summary

  • As of today (June 4, 2025), LGND TTM capital expenditures is $19.13 million, with the most recent change of -$513.00 thousand (-2.61%) on March 31, 2025.
  • Over the past year, LGND TTM CAPEX has dropped by -$34.86 million (-64.57%).
  • LGND TTM CAPEX is now -82.53% below its all-time high of $109.47 million, reached on December 31, 2002.

Performance

LGND TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDcash flow metrics

LGND CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-63.5%-20.1%-64.6%
3 y3 years+124.2%-58.3%+86.9%
5 y5 years+669.3%--

LGND CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-63.5%+124.2%-96.0%+902.5%-72.5%+347.4%
5 y5-year-63.5%+669.3%-96.0%+902.5%-72.5%+2318.1%
alltimeall time-82.1%+9720.0%-98.1%+129.1%-82.5%>+9999.0%

LGND CAPEX History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.04M(+185.8%)
$19.13M(-2.6%)
Dec 2024
$19.64M(-63.5%)
$712.00K(-95.0%)
$19.64M(-71.8%)
Sep 2024
-
$14.24M(+565.8%)
$69.67M(+24.6%)
Jun 2024
-
$2.14M(-16.1%)
$55.92M(+3.6%)
Mar 2024
-
$2.55M(-95.0%)
$53.98M(+0.2%)
Dec 2023
$53.85M(+200.4%)
$50.74M(>+9900.0%)
$53.85M(+1159.6%)
Sep 2023
-
$487.00K(+139.9%)
$4.28M(-52.9%)
Jun 2023
-
$203.00K(-91.6%)
$9.08M(-41.3%)
Mar 2023
-
$2.41M(+106.1%)
$15.46M(-13.7%)
Dec 2022
$17.92M(+104.6%)
$1.17M(-77.9%)
$17.92M(-5.4%)
Sep 2022
-
$5.29M(-19.7%)
$18.95M(+22.8%)
Jun 2022
-
$6.59M(+35.1%)
$15.43M(+50.8%)
Mar 2022
-
$4.88M(+122.1%)
$10.23M(+16.8%)
Dec 2021
$8.76M(+96.5%)
$2.19M(+23.9%)
$8.76M(+6.9%)
Sep 2021
-
$1.77M(+27.5%)
$8.20M(-3.1%)
Jun 2021
-
$1.39M(-59.2%)
$8.46M(+7.6%)
Mar 2021
-
$3.40M(+108.8%)
$7.86M(+76.4%)
Dec 2020
$4.46M(+74.6%)
$1.63M(-20.0%)
$4.46M(+57.6%)
Sep 2020
-
$2.04M(+157.5%)
$2.83M(+257.5%)
Jun 2020
-
$791.00K(-111.3%)
$791.00K(-96.0%)
Dec 2019
$2.55M(-76.6%)
-
-
Dec 2018
$10.89M(+405.0%)
-
-
Dec 2017
$2.16M(-89.0%)
-
-
Dec 2016
$19.55M(+79.9%)
-$6.99M(-419.7%)
$19.55M(-31.2%)
Sep 2016
-
$2.19M(-88.3%)
$28.40M(+3.3%)
Jun 2016
-
$18.66M(+228.3%)
$27.49M(+106.8%)
Mar 2016
-
$5.68M(+204.8%)
$13.29M(+22.3%)
Dec 2015
$10.86M(+141.5%)
$1.86M(+45.9%)
$10.86M(-6.0%)
Sep 2015
-
$1.28M(-71.4%)
$11.56M(+9.6%)
Jun 2015
-
$4.46M(+37.0%)
$10.55M(+72.1%)
Mar 2015
-
$3.26M(+27.1%)
$6.13M(+36.3%)
Dec 2014
$4.50M(-8.9%)
$2.56M(+856.3%)
$4.50M(+53.1%)
Sep 2014
-
$268.00K(+509.1%)
$2.94M(+2.2%)
Jun 2014
-
$44.00K(-97.3%)
$2.88M(-55.9%)
Mar 2014
-
$1.62M(+61.9%)
$6.52M(+32.1%)
Dec 2013
$4.94M(-42.9%)
$1.00M(+389.3%)
$4.94M(+26.7%)
Sep 2013
-
$205.00K(-94.4%)
$3.90M(-48.5%)
Jun 2013
-
$3.69M(+9878.4%)
$7.56M(+83.9%)
Mar 2013
-
$37.00K(-197.4%)
$4.11M(-52.4%)
Dec 2012
$8.64M(+192.7%)
-$38.00K(-101.0%)
$8.64M(-25.0%)
Sep 2012
-
$3.87M(+1500.0%)
$11.52M(+48.5%)
Jun 2012
-
$242.00K(-94.7%)
$7.76M(+3.2%)
Mar 2012
-
$4.57M(+61.0%)
$7.52M(+154.5%)
Dec 2011
$2.95M(+124.2%)
$2.84M(+2455.9%)
$2.95M(<-9900.0%)
Sep 2011
-
$111.00K(>+9900.0%)
-$12.00K(-89.8%)
Jun 2011
-
$0.00(-100.0%)
-$118.00K(-109.3%)
Mar 2011
-
$5000.00(-103.9%)
$1.27M(-3.9%)
Dec 2010
$1.32M(+152.3%)
-$128.00K(-2660.0%)
$1.32M(-7.9%)
Sep 2010
-
$5000.00(-99.6%)
$1.43M(-12.9%)
Jun 2010
-
$1.38M(+2371.4%)
$1.64M(+351.1%)
Mar 2010
-
$56.00K(-473.3%)
$364.00K(-30.3%)
Dec 2009
$522.00K(+5.5%)
-$15.00K(-106.9%)
$522.00K(-9.7%)
Sep 2009
-
$217.00K(+104.7%)
$578.00K(+34.4%)
Jun 2009
-
$106.00K(-50.5%)
$430.00K(-16.2%)
Mar 2009
-
$214.00K(+422.0%)
$513.00K(+3.6%)
Dec 2008
$495.00K
$41.00K(-40.6%)
$495.00K(-5.7%)
DateAnnualQuarterlyTTM
Sep 2008
-
$69.00K(-63.5%)
$525.00K(+6.3%)
Jun 2008
-
$189.00K(-3.6%)
$494.00K(-10.2%)
Mar 2008
-
$196.00K(+176.1%)
$550.00K(+25.0%)
Dec 2007
$440.00K(-75.3%)
$71.00K(+86.8%)
$440.00K(-21.4%)
Sep 2007
-
$38.00K(-84.5%)
$560.00K(-61.1%)
Jun 2007
-
$245.00K(+184.9%)
$1.44M(-14.2%)
Mar 2007
-
$86.00K(-55.0%)
$1.68M(-5.8%)
Dec 2006
$1.78M(-95.0%)
$191.00K(-79.2%)
$1.78M(-4.1%)
Sep 2006
-
$918.00K(+89.7%)
$1.86M(-94.7%)
Jun 2006
-
$484.00K(+154.7%)
$35.13M(-0.2%)
Mar 2006
-
$190.00K(-29.1%)
$35.19M(-1.1%)
Dec 2005
$35.60M(+887.7%)
$268.00K(-99.2%)
$35.60M(-1.4%)
Sep 2005
-
$34.18M(+6137.8%)
$36.09M(+1222.9%)
Jun 2005
-
$548.00K(-8.2%)
$2.73M(-16.0%)
Mar 2005
-
$597.00K(-21.6%)
$3.25M(-9.9%)
Dec 2004
$3.60M(-47.9%)
$761.00K(-7.4%)
$3.60M(-57.7%)
Sep 2004
-
$822.00K(-23.1%)
$8.52M(+0.3%)
Jun 2004
-
$1.07M(+12.3%)
$8.49M(+11.3%)
Mar 2004
-
$952.00K(-83.2%)
$7.63M(+10.3%)
Dec 2003
$6.92M(-93.7%)
$5.67M(+612.9%)
$6.92M(-93.6%)
Sep 2003
-
$796.00K(+284.5%)
$107.83M(+0.1%)
Jun 2003
-
$207.00K(-13.0%)
$107.74M(-0.4%)
Mar 2003
-
$238.00K(-99.8%)
$108.21M(-1.1%)
Dec 2002
$109.47M(+5445.3%)
$106.58M(>+9900.0%)
$109.47M(+3194.2%)
Sep 2002
-
$709.00K(+4.9%)
$3.32M(+18.5%)
Jun 2002
-
$676.00K(-54.8%)
$2.81M(+7.6%)
Mar 2002
-
$1.50M(+237.5%)
$2.61M(+32.0%)
Dec 2001
$1.97M(+81.9%)
$443.00K(+131.9%)
$1.97M(+25.0%)
Sep 2001
-
$191.00K(-60.0%)
$1.58M(+0.6%)
Jun 2001
-
$477.00K(-44.7%)
$1.57M(-3.1%)
Mar 2001
-
$863.00K(+1697.9%)
$1.62M(+49.4%)
Dec 2000
$1.08M(-54.8%)
$48.00K(-73.6%)
$1.08M(-18.8%)
Sep 2000
-
$182.00K(-65.5%)
$1.34M(-23.8%)
Jun 2000
-
$528.00K(+61.5%)
$1.75M(-21.2%)
Mar 2000
-
$327.00K(+9.0%)
$2.23M(-7.2%)
Dec 1999
$2.40M(0.0%)
$300.00K(-50.0%)
$2.40M(-29.4%)
Sep 1999
-
$600.00K(-40.0%)
$3.40M(+209.1%)
Jun 1999
-
$1.00M(+100.0%)
$1.10M(-47.6%)
Mar 1999
-
$500.00K(-61.5%)
$2.10M(-12.5%)
Dec 1998
$2.40M(-44.2%)
$1.30M(-176.5%)
$2.40M(+41.2%)
Sep 1998
-
-$1.70M(-185.0%)
$1.70M(-52.8%)
Jun 1998
-
$2.00M(+150.0%)
$3.60M(-28.0%)
Mar 1998
-
$800.00K(+33.3%)
$5.00M(+16.3%)
Dec 1997
$4.30M(+975.0%)
$600.00K(+200.0%)
$4.30M(+19.4%)
Sep 1997
-
$200.00K(-94.1%)
$3.60M(0.0%)
Jun 1997
-
$3.40M(+3300.0%)
$3.60M(+3500.0%)
Mar 1997
-
$100.00K(-200.0%)
$100.00K(-75.0%)
Dec 1996
$400.00K(+100.0%)
-$100.00K(-150.0%)
$400.00K(-20.0%)
Sep 1996
-
$200.00K(-300.0%)
$500.00K(+66.7%)
Jun 1996
-
-$100.00K(-125.0%)
$300.00K(-25.0%)
Mar 1996
-
$400.00K(+33.3%)
$400.00K(-42.9%)
Dec 1995
$200.00K(-66.7%)
-
-
Mar 1995
-
$300.00K(0.0%)
$700.00K(+16.7%)
Dec 1994
$600.00K
$300.00K(+200.0%)
$600.00K(+100.0%)
Sep 1994
-
$100.00K(>+9900.0%)
$300.00K(+50.0%)
Jun 1994
-
$0.00(-100.0%)
$200.00K(0.0%)
Mar 1994
-
$200.00K
$200.00K

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual capital expenditures?
  • What is the all time high annual CAPEX for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual CAPEX year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated TTM capital expenditures?
  • What is the all time high TTM CAPEX for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated TTM CAPEX year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual capital expenditures?

The current annual CAPEX of LGND is $19.64M

What is the all time high annual CAPEX for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual capital expenditures is $109.47M

What is Ligand Pharmaceuticals Incorporated annual CAPEX year-on-year change?

Over the past year, LGND annual capital expenditures has changed by -$34.21M (-63.53%)

What is Ligand Pharmaceuticals Incorporated quarterly capital expenditures?

The current quarterly CAPEX of LGND is $2.04M

What is the all time high quarterly CAPEX for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly capital expenditures is $106.58M

What is Ligand Pharmaceuticals Incorporated quarterly CAPEX year-on-year change?

Over the past year, LGND quarterly capital expenditures has changed by -$513.00K (-20.13%)

What is Ligand Pharmaceuticals Incorporated TTM capital expenditures?

The current TTM CAPEX of LGND is $19.13M

What is the all time high TTM CAPEX for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high TTM capital expenditures is $109.47M

What is Ligand Pharmaceuticals Incorporated TTM CAPEX year-on-year change?

Over the past year, LGND TTM capital expenditures has changed by -$34.86M (-64.57%)
On this page